Cognitive Function of Thyroid Papillary Carcinoma Patients Before Radioiodine Therapy.
- Author:
Hyun Seuk KIM
;
Jin Sook CHEON
;
Min Su KIM
;
Young Sik CHOI
;
Byoung Hoon OH
- Publication Type:Original Article
- Keywords:
Thyroid cancer;
Cognitive function;
Korean Version of the Montreal Cognitive Assessment;
Age;
Education;
Thyroid stimulating hormone
- MeSH:
Carcinoma, Papillary*;
Comorbidity;
Depression;
Education;
Humans;
Prevalence;
Thyroid Gland*;
Thyroid Neoplasms;
Thyroidectomy;
Thyrotropin
- From:Korean Journal of Psychosomatic Medicine
2013;21(2):132-139
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVES: The aims of this study were to know the prevalence of cognitive disorders in patients with thyroid cancer, and identify related variables to them. METHODS: Subjects were consisted of fourty-two patients with thyroid cancer, who were admitted for radioiodine ablative therapy at 6-12 months after total thyroidectomy. The data were obtained from interviews about history and assessments of depression and cognitive function(Korean Version of the Montreal Cognitive Assessment, MoCA-K). RESULTS: 1) Among subjects, those with below 22 of total score of the MoCA-K were twenty-one(50.0%). 2) Upon age, education, Pre-radioiodine therapy thyroid stimulating hormone(TSH), there were statistically significant difference between subgroup with above 23 of the total MoCA-K score and those below 22. 3) The total scores of the MoCA-K in subjects had significant correlation with age, education, comorbidity, Pre-radioiodine therapy TSH, total score of the HDRS-17. CONCLUSIONS: Cognitive disorders were more prevalent among patients with thyroid cancer before radioiodine therapy. Therefore, further study should be needed to clarify the mechanism for the cognitive disorders in thyroid cancer. Furthermore, physicians should pay attention to the cognitive function and prepare preventative measures for cognitive disorder during management of thyroid cancer.
